Literature DB >> 3057887

Role of abnormal free fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus.

G M Reaven1, Y D Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3057887     DOI： 10.1016/0002-9343(88)90402-0

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  16 in total

Review 1.  Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials.

Authors:  Amirhossein Sahebkar; Luis E Simental-Mendía; Claudio Pedone; Gianna Ferretti; Petr Nachtigal; Simona Bo; Giuseppe Derosa; Pamela Maffioli; Gerald F Watts
Journal:  Br J Clin Pharmacol       Date:  2016-02-02       Impact factor: 4.335

2.  Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.

Authors:  Yanqiao Zhang; Florence Ying Lee; Gabriel Barrera; Hans Lee; Charisse Vales; Frank J Gonzalez; Timothy M Willson; Peter A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-12       Impact factor: 11.205

Review 3.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

4.  Cathepsin B regulates hepatic lipid metabolism by cleaving liver fatty acid-binding protein.

Authors:  Simeon Thibeaux; Shaila Siddiqi; Olga Zhelyabovska; Faisal Moinuddin; Michal M Masternak; Shadab A Siddiqi
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

Review 5.  ATP binding cassette transporter A1--key roles in cellular lipid transport and atherosclerosis.

Authors:  Neelam Srivastava
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

6.  Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects.

Authors:  Hanyu Liang; Puntip Tantiwong; Apiradee Sriwijitkamol; Karthigayan Shanmugasundaram; Sumathy Mohan; Sara Espinoza; Ralph A Defronzo; John J Dubé; Nicolas Musi
Journal:  J Physiol       Date:  2013-03-25       Impact factor: 5.182

7.  Physiological indirect effect modeling of the antilipolytic effects of adenosine A1-receptor agonists.

Authors:  E A van Schaick; H J de Greef; A P Ijzerman; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1997-12

Review 8.  Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style?

Authors:  J Holte
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

9.  Fasting, post-OGTT challenge, and nocturnal free fatty acids in prediabetic versus normal glucose tolerant overweight and obese Latino adolescents.

Authors:  Claudia M Toledo-Corral; Tanya L Alderete; Joyce Richey; Paola Sequeira; Michael I Goran; Marc J Weigensberg
Journal:  Acta Diabetol       Date:  2014-08-11       Impact factor: 4.280

10.  TAK-242, a small-molecule inhibitor of Toll-like receptor 4 signalling, unveils similarities and differences in lipopolysaccharide- and lipid-induced inflammation and insulin resistance in muscle cells.

Authors:  Sophie E Hussey; Hanyu Liang; Sheila R Costford; Amira Klip; Ralph A DeFronzo; Alicia Sanchez-Avila; Brian Ely; Nicolas Musi
Journal:  Biosci Rep       Date:  2012-11-30       Impact factor: 3.840
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.